Abbrea Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.2M | Buy |
32,936
+484
| +1% | +$44.6K | 0.42% | 52 |
|
|
2024
Q1 | $2.92M | Sell |
32,452
-6,400
| -16% | -$542K | 0.38% | 54 |
|
|
2023
Q4 | $3.1M | Sell |
38,852
-280
| -0.7% | -$21.1K | 0.45% | 49 |
|
|
2023
Q3 | $2.78M | Sell |
39,132
-370
| -0.9% | -$27.7K | 0.44% | 52 |
|
|
2023
Q2 | $3.04M | Buy |
39,502
+207
| +0.5% | +$16K | 0.47% | 51 |
|
|
2023
Q1 | $2.95M | Sell |
39,295
-1,112
| -3% | -$82.7K | 0.5% | 52 |
|
|
2022
Q4 | $3.18M | Sell |
40,407
-1,025
| -2% | -$76.8K | 0.57% | 47 |
|
|
2022
Q3 | $2.91M | Hold |
41,432
| – | – | 0.55% | 44 |
|
|
2022
Q2 | $3.32M | Buy |
41,432
+657
| +2% | +$51.4K | 0.55% | 44 |
|
|
2022
Q1 | $3.09M | Sell |
40,775
-140
| -0.3% | -$11.1K | 0.43% | 55 |
|
|
2021
Q4 | $3.49M | Buy |
40,915
+120
| +0.3% | +$9.37K | 0.47% | 51 |
|
|
2021
Q3 | $3.08M | Buy |
40,795
+1,000
| +3% | +$79.4K | 0.46% | 53 |
|
|
2021
Q2 | $3.24M | Buy |
39,795
+31
| +0.1% | +$2.54K | 0.49% | 53 |
|
|
2021
Q1 | $3.13M | Buy |
39,764
+260
| +0.7% | +$20.4K | 0.52% | 50 |
|
|
2020
Q4 | $3.38M | Buy |
39,504
+297
| +0.8% | +$24.6K | 0.6% | 42 |
|
|
2020
Q3 | $3.02M | Hold |
39,207
| – | – | 0.64% | 41 |
|
|
2020
Q2 | $2.87M | Buy |
39,207
+283
| +0.7% | +$20.1K | 0.66% | 41 |
|
|
2020
Q1 | $2.58M | Sell |
38,924
-60
| -0.2% | -$4.23K | 0.69% | 40 |
|
|
2019
Q4 | $2.68M | Sell |
38,984
-354
| -0.9% | -$24.1K | 0.57% | 45 |
|
|
2019
Q3 | $2.89M | Buy |
39,338
+162
| +0.4% | +$11.8K | 0.67% | 42 |
|
|
2019
Q2 | $2.81M | Buy |
39,176
+18,051
| +85% | +$1.28M | 0.69% | 44 |
|
|
2019
Q1 | $1.45M | Buy |
21,125
+377
| +2% | +$24.4K | 0.42% | 66 |
|
|
2018
Q4 | $1.24M | Buy |
20,748
+748
| +4% | +$46.8K | 0.41% | 68 |
|
|
2018
Q3 | $1.34M | Buy |
20,000
+67
| +0.3% | +$4.46K | 0.39% | 65 |
|
|
2018
Q2 | $1.29M | Sell |
19,933
-78
| -0.4% | -$5.1K | 0.41% | 63 |
|
|
2018
Q1 | $1.43M | Sell |
20,011
-59
| -0.3% | -$4.25K | 0.46% | 57 |
|
|
2017
Q4 | $1.51M | Hold |
20,070
| – | – | 0.52% | 56 |
|
|
2017
Q3 | $1.46M | Sell |
20,070
-600
| -3% | -$43.2K | 0.54% | 55 |
|
|
2017
Q2 | $1.53M | Hold |
20,670
| – | – | 0.61% | 51 |
|
|
2017
Q1 | $1.51M | Buy |
20,670
+212
| +1% | +$14.8K | 0.62% | 53 |
|
|
2016
Q4 | $1.34M | Buy |
+20,458
| New | +$1.4M | 0.63% | 52 |
|
Other funds holding CL
Abbrea Capital's CL Position: Q2 2024 in Review
Abbrea Capital increased its Colgate-Palmolive (CL) stake by 1.5% in Q2 2024, buying an estimated $44.6K and bringing the position to 32,936 shares worth $3.2M. The position accounts for 0.42% of the portfolio, ranked #52.
Abbrea Capital first reported a position in CL in Q4 2016 and has held it in 31 quarters since. The position peaked at $3.49M in Q4 2021. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.
- Abbrea Capital held 32,936 shares of Colgate-Palmolive worth $3.2M as of Q2 2024.
- Abbrea Capital bought 484 Colgate-Palmolive shares in Q2 2024, an estimated $44.6K.
- Colgate-Palmolive made up 0.42% of Abbrea Capital's portfolio in Q2 2024, its #52 holding.
- Abbrea Capital first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 31 quarters since.
- Abbrea Capital's Colgate-Palmolive position peaked at $3.49M in Q4 2021.
- 1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.
Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.